The Work We Fund

Funded projects
1,250+
Men's Health Partners
20
Countries
20
We work closely with our global men's health partners to ensure collaboration, transparency and accountability for every project we fund. We monitor this through report cards which detail what we seek to achieve, key measures and the impact.
Prostate Cancer
"Together with the brightest minds in research, we aim to achieve significant breakthroughs in the hope of beating prostate cancer. Our disruptive funding approach identifies revolutionary ways to accelerate health outcomes by creating strong, global collaborative teams." Dr. Colleen Nelson, Global Scientific Chair.
Men's Health
"One Mo can help change the face of men’s health through the powerful conversations created globally during Movember. Men have the chance to confidently discuss men’s health with people around them, resulting in men taking action early, helping change and save lives." Paul Villanti, Executive Director, Programs
Mental health and suicide prevention
“The number of men taking their own lives around the world is one of the biggest challenges of our time. Movember is working to ensure all men and boys look after their mental health and are comfortable to seek help when they’re struggling.”
Brendan Maher, Global Director, Mental Health and Suicide Prevention.
Testicular Cancer
“Despite being the 2nd most common cancer in young men, testicular cancer is often a forgotten cancer due to early detection and treatment. Our projects look at underinvested areas such as improving access to healthcare services and treatment options for relapse” Paul Villanti, Executive Director, Programs.

Research - Young Investigator Awards, New Concept and Equipment Grants

Movember Funding to Date

AUD 29,421,880

What we seek to achieve

To make discoveries which will improve the length and quality of life of men with prostate cancer, especially prostate cancer which cannot be cured by surgery or radiation therapy.

Country
Australia
Implemented by
Prostate Cancer Foundation of Australia (PCFA)
Project start date
2007
Project Status
Project Completed

About the project

Each year, the program calls for applications of funding in the following priority areas:

  • Discover the genetic and cellular factors which initiate and/or perpetuate prostate cancer
  • Discover new specific tests to detect prostate cancer
  • Discover, develop and clinically validate new biomarkers to monitor treatment
  • Discover new targeted treatment for locally-invasive or metastatic prostate cancer
  • Provide immediate improvements in the quality of life of patients with prostate cancer

The program funds the best prostate cancer research in all four categories via an expert peer review process monitored by our Research Advisory Committee. Progress is monitored via annual reports submitted by the grantees.

In the 2011 funding round, 87 applications were received for funding in 4 categories: Young Investigator (YI), New Direction Development Awards (NDDA), Concept Grants (CG) and Equipment Grants (EG) .
Each grant was assigned at least two reviewers, which included one international expert reviewer, with specific expertise in all cancer disciplines, exceeding the NHMRC peer review standard.
 

>
Page 1 of 29